Pulmonx Free Cash Flow 2019-2024 | LUNG
Pulmonx free cash flow from 2019 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Pulmonx Annual Free Cash Flow | |
|---|---|
| 2024 | -32.98 |
| 2023 | -38.42 |
| 2022 | -46.40 |
| 2021 | -45.06 |
| 2020 | -31.54 |
| 2019 | -21.49 |
| 2018 | -18.69 |
| Pulmonx Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | -32.98 |
| 2024-09-30 | -26.14 |
| 2024-06-30 | -18.49 |
| 2024-03-31 | -12.25 |
| 2023-12-31 | -38.42 |
| 2023-09-30 | -29.77 |
| 2023-06-30 | -20.65 |
| 2023-03-31 | -12.71 |
| 2022-12-31 | -46.40 |
| 2022-09-30 | -36.42 |
| 2022-06-30 | -25.45 |
| 2022-03-31 | -15.59 |
| 2021-12-31 | -45.06 |
| 2021-09-30 | -33.20 |
| 2021-06-30 | -23.27 |
| 2021-03-31 | -9.91 |
| 2020-12-31 | -31.54 |
| 2020-09-30 | -23.59 |
| 2020-06-30 | -17.68 |
| 2020-03-31 | -9.93 |
| 2019-12-31 | |
| 2019-09-30 | -17.79 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.152B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||